Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Menopause (New York, N.Y.)|August 5, 1998
Relationship between circulating estradiol levels, body mass index, and breakthrough bleeding in postmenopausal women receiving hormone replacement therapyE Büyük, A Gürler, M ErenusYonsei Medical Journal|March 24, 1998
Clinical manifestations of Behçet's disease: an analysis of 2147 patientsA Gürler, A Boyvat, U TürsenClimacteric : the Journal of the International Menopause Society|October 9, 2001
Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and complianceM Erenus, B Karakoç, A GürlerDermatology (Basel, Switzerland)|September 6, 2000
Long-term effects of interferon alpha 2A treatment in Behçet's diseaseA Boyvat, C Sişman-Solak, A GürlerThe Journal of Rheumatology|March 28, 1998
Factor V Leiden mutation in patients with Behçet's diseaseA F Oner, A Gürgey, A Gürler, et al.Cardiovascular Surgery (London, England)|June 1, 1996
Evaluation of peripheral vascular system disorders in vascular symptom--free Behçet's diseaseA Kuzu, C Köksoy, C Ozaslan, et al.Allergologia Et Immunopathologia|July 1, 1997
Bronchial hyperreactivity and immunoglobulin E in Behçet's diseaseA F Kalpaklioğlu, L Gürbüz, A Gürler, et al.Rheumatology International|January 1, 1996
Fibronectin and circulating immune complexes in Behet's diseaseK Ozoran, N Düzgün, H Tutkak, et al.Scandinavian Journal of Rheumatology|January 1, 1995
Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet's diseaseK Ozoran, N Dügün, A Gürler, et al.World Journal of Surgery|November 1, 1994
Vascular involvement in Behçet's disease: 8-year auditM A Kuzu, C Ozaslan, C Köksoy, et al.Pageof 3